Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients.

@article{Gmez2010PrognosticEO,
  title={Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients.},
  author={Henry Leonidas G{\'o}mez and C A Castaneda and Carlos E Vigil and Tatiana Vidaurre and Ra{\'u}l G Velarde and Wilder R Cruz and Joseph A. Pinto and Juan F Suazo and Milko R Garc{\'e}s and Silvia P Neciosup and Carlos Santiago Vallejos},
  journal={Hematology/oncology and stem cell therapy},
  year={2010},
  volume={3 3},
  pages={109-15}
}
BACKGROUND This study was conducted to determine the prognostic effect hormone receptor (HR) status in early HER2 positive (HER2+) breast cancer patients, since it has not yet been established whether HR status can be used in the prognosis of patients with (HER2+) breast cancer. PATIENTS AND METHODS We obtained data from 299 patients with early HER2… CONTINUE READING